REBIOTIX A FERRING COMPANY

What this means for you

This application is over — abandoned 01 Mar 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

88276773

Mark type

Design + words

Filed

25 Jan 2019

Published for opposition

28 May 2019

Abandoned

01 Mar 2021

Attorney of record

Michael T. Hess

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical and biopharmaceutical agents used for the treatment of diseases and disorders emanating from microbiota dysfunction; pharmaceutical and biopharmaceutical agents used for the treatment of diseases and disorders in the fields of gastroenterology, reproductive health, metabolic health, endocrinology; pharmaceutical and biopharmaceutical agents used for the treatment of gastrointestinal, infectious, metabolic, liver, inflammatory and neurological diseases and disorders
• Class 042 — Scientific and technological services: Medical and scientific research; providing medical and scientific research information in the field of clinical trials

Owner

• REBIOTIX, INC., Roseville, MN, US
• REBIOTIX, INC., Roseville, MN, US

Prosecution history

• 01 Mar 2021 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
• 01 Mar 2021 — ABANDONMENT - NO USE STATEMENT FILED
• 11 Aug 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 09 Aug 2020 — SOU EXTENSION 2 GRANTED
• 21 Jul 2020 — SOU EXTENSION 2 FILED
• 09 Aug 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 21 Jul 2020 — SOU TEAS EXTENSION RECEIVED
• 24 Jan 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 22 Jan 2020 — SOU EXTENSION 1 GRANTED
• 22 Jan 2020 — SOU EXTENSION 1 FILED
• 22 Jan 2020 — SOU TEAS EXTENSION RECEIVED
• 23 Jul 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 28 May 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 28 May 2019 — PUBLISHED FOR OPPOSITION
• 08 May 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED